1 in 11 men in the UK will be diagnosed with prostate cancer
"Prostate cancer as an issue is gaining ground but still too slowly. To make the progress we need in raising awareness, accelerating research and improving NHS services, the pace of change has to step up a gear. We are inviting you to join a movement for change a movement that will, with your help, succeed.
All men in the UK must know about prostate cancer and the symptoms to look out for knowledge that could save their lives. Many people have already joined us to build awareness and understanding across the age groups. Now is the time for all men and their families to unite to put their health first.
Every man diagnosed with prostate cancer must have access to excellent information, health care and support. The Prostate Cancer Charity is leading this challenge not only through the services it provides, but also through its determination to influence the NHS and health professionals.
More money much more must be invested in research into improved testing, diagnosis and treatment of prostate cancer. Although national research spend is rising, we must never forget that we have a historical legacy of neglect to overcome.
We invested £1.5 million in 2004/05 in high quality research, demonstrating our own commitment to this vital area of activity. None of our work would be possible without the help of the many people who have already thrown their weight behind us. We thank all of our supporters including individuals who give donations and legacies, people prepared to volunteer their precious time, and companies and charitable trusts who want to improve mens health.
We recognise that much more can be achieved together than apart. That is why The Prostate Cancer Charity is committed to mobilising others, locally and nationally, and to working with them in harnessing our collective efforts.
Please join us in meeting the challenges that lie ahead. Think about how, together, we can build on the initiatives and activities that are set out in this Annual Review. We look forward to hearing from you."
John Neate, Chief Executive and Paul Forster, Chairman
back: Annual Review index | next: Investment in research